We are live on ! Find out more
GRCL

Gracell Biotechnologies Inc. American Depositary Shares
GRCL

Delisted

GRCL was delisted on the 21st of February, 2024.

Back to rankings

0 hedge funds and large institutions have $0 invested in Gracell Biotechnologies Inc. American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 63 → 0 (-63)

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $553M → $0 (-$553M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 63

Holders
–
Holders Change
-63
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
63
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Temasek Holdings
Temasek Holdings
Singapore
-$96.3M
2
VC
Vivo Capital
California
-$95.8M
3
O
OrbiMed
New York
-$93.5M
4
SCM
Sio Capital Management
New York
-$50.2M
5
TCM
TCG Crossover Management
California
-$45.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Temasek Holdings
1
Temasek Holdings
Singapore
– -$96.3M -9,588,863 Closed
VC
2
Vivo Capital
California
– -$95.8M -9,546,485 Closed
O
3
OrbiMed
New York
– -$93.5M -9,308,726 Closed
SCM
4
Sio Capital Management
New York
– -$50.2M -5,001,580 Closed
TCM
5
TCG Crossover Management
California
– -$45.3M -4,514,786 Closed
TCM
6
Tang Capital Management
California
– -$22M -2,191,417 Closed
BBA
7
Baker Bros. Advisors
New York
– -$20.9M -2,080,000 Closed
PCM
8
Pentwater Capital Management
Florida
– -$14.7M -1,461,000 Closed
PBPIA
9
Pivotal bioVenture Partners Investment Advisor
California
– -$13.8M -1,375,000 Closed
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
– -$13.6M -1,350,000 Closed
TAL
11
TIG Advisors LLC
New York
– -$12.8M -1,279,595 Closed
AAM
12
Alpine Associates Management
Florida
– -$12.8M -1,278,454 Closed
OCA
13
Octagon Capital Advisors
New York
– -$5.99M -596,611 Closed
BlackRock
14
BlackRock
New York
– -$5.42M -539,973 Closed
Qube Research & Technologies (QRT)
15
Qube Research & Technologies (QRT)
United Kingdom
– -$5.19M -517,274 Closed
Bank of America
16
Bank of America
North Carolina
– -$5.14M -511,953 Closed
LP
17
LMR Partners
United Kingdom
– -$3.31M -510,001 Closed
SFM
18
Sphera Funds Management
Israel
– -$5.05M -502,936 Closed
MI
19
MMCAP International
Cayman Islands
– -$4.53M -451,172 Closed
HM
20
Harvest Management
New York
– -$4.02M -400,000 Closed
Hudson Bay Capital Management
21
Hudson Bay Capital Management
Connecticut
– -$2.68M -266,667 Closed
Marshall Wace
22
Marshall Wace
United Kingdom
– -$1.93M -192,465 Closed
Millennium Management
23
Millennium Management
New York
– -$1.92M -191,269 Closed
Morgan Stanley
24
Morgan Stanley
New York
– -$1.57M -156,238 Closed
AA
25
AQR Arbitrage
Connecticut
– -$1.31M -130,779 Closed
1
2 3

GRCL Hedge Fund Activity: Q1 2024 in Review

0 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Gracell Biotechnologies Inc. American Depositary Shares (GRCL) for Q1 2024, worth a combined $0 — down 100% from $553M a quarter earlier.

Sellers outnumbered buyers: 63 funds closed out of GRCL and 0 opened new positions — a net loss of 63 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Temasek Holdings, exiting entirely with an estimated $96.3M sold.

  • 0 institutional investors held Gracell Biotechnologies Inc. American Depositary Shares (GRCL) as of Q1 2024, down from 63 in Q4 2023.
  • Funds reported $0 of Gracell Biotechnologies Inc. American Depositary Shares stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Gracell Biotechnologies Inc. American Depositary Shares positions in Q1 2024 and 63 closed out, a net change of -63 holders.
  • The largest Gracell Biotechnologies Inc. American Depositary Shares seller in Q1 2024 was Temasek Holdings, an estimated $96.3M sold.

Based on aggregated 13F filings for Q1 2024.